Pliant Therapeutics is laying off 45% of its staff, about 75 employees, after halting a key fibrosis drug study due to safety concerns, the South San Francisco biotech announced in an SEC filing. #southsanfrancisco #sanfrancisco #plianttherapeutics #fibrosis #bayarea #layoffs #bayarealayoffs
0
0
0
0